![]() |
市场调查报告书
商品编码
1630684
电子处方笺市场规模、份额、增长分析,按产品类型、按交付方式、按最终用户、按用途、按物质、按专业和按地区 - 行业预测,2025-2032 年E-Prescription Market Size, Share, Growth Analysis, By Product Type (Solutions, Services), By Delivery Mode (Web-based, Cloud-based), By End-User, By Usage Methods, By Substances, By Specialties, By Region - Industry Forecast 2025-2032 |
2023 年全球电子处方笺市场规模价值为 36.6 亿美元,预计将从 2024 年的 46.4 亿美元成长到 2032 年的 310.1 亿美元,预测期内(2025-2032 年)的复合年增长率为 26.8%。
处方错误占医疗保健机构报告的用药相关事故的 72% 以上,引起了全球医疗保健专业人士的极大关注。虽然此类错误很少导致死亡,但它们会给患者带来严重的健康风险,并经常导致对医疗专业人员的法律诉讼。为了解决这个问题,电子处方(e-prescribing)已成为一种有效的解决方案。该技术使医疗保健专业人员能够以电子方式将处方笺发送到药房,最大限度地减少药物交互作用,并透过减少错误来提高患者的安全性。此外,电子处方比传统方法更具成本效益和效率,简化了处方流程。预计各类医疗机构都将采用电子处方系统,这表明对于此项技术在改善医疗品质方面的需求日益增长。
Global E-Prescription Market size was valued at USD 3.66 billion in 2023 and is poised to grow from USD 4.64 billion in 2024 to USD 31.01 billion by 2032, growing at a CAGR of 26.8% during the forecast period (2025-2032).
Prescription errors represent over 72% of drug-related incidents reported in healthcare settings, raising significant concerns for medical practitioners globally. While these mistakes rarely lead to fatalities, they pose serious health risks for patients and often result in legal actions against healthcare professionals. To combat this issue, electronic prescribing (e-prescribing) has emerged as an effective solution. This technology allows medical providers to electronically send prescriptions to pharmacies, enhancing patient safety by minimizing drug interactions and reducing errors. Additionally, e-prescribing offers a more cost-effective and efficient alternative to traditional methods, streamlining the prescription process. The anticipated growth in the adoption of e-prescribing systems across various medical facilities indicates a rising demand for this technology in enhancing the quality of care.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global E-Prescription market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global E-Prescription Market Segmental Analysis
Global E-Prescription Market is segmented by Product Type, Delivery Mode, End-User, Usage Methods, Substances, Specialties and region. Based on Product Type, the market is segmented into Solutions and Services. Based on Delivery Mode, the market is segmented into Web-based, Cloud-based and On-premise. Based on End-User, the market is segmented into Hospitals, Clinics, Pharmacies, Ambulatory Surgical Centers and Others. Based on Usage Methods, the market is segmented into Handheld and Computer Based Devices. Based on Substances, the market is segmented into Controlled Substances and Non-controlled Substances. Based on Specialties, the market is segmented into Oncology, Sports Medicine, Neurology, Cardiology and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global E-Prescription Market
One of the key drivers of the global e-prescription market is the growing emphasis on eliminating adverse drug events (ADEs) and reducing medical errors in healthcare. Medication mistakes can significantly compromise patient health, making it essential for healthcare providers to utilize robust e-prescribing systems. These systems enable clinicians to access comprehensive patient records, including medical histories, current medications, and diagnoses, thereby enhancing patient safety and minimizing the likelihood of errors. As the incidence of medication errors and drug-related side effects continues to escalate worldwide, the demand for e-prescribing solutions is expected to surge, further propelling market growth.
Restraints in the Global E-Prescription Market
The global e-prescription market faces significant restraints, primarily due to the high expenses associated with the implementation and maintenance of integrated e-prescribing systems. Even though these systems are gaining traction in various clinical environments, their steep costs deter broader acceptance, particularly in developing regions where financial resources are limited. Moreover, the absence of adequate healthcare IT infrastructure in many emerging economies further hinders the growth of this market. As a result, the combination of high investment requirements and insufficient support systems poses a considerable challenge to the widespread adoption of e-prescribing solutions across the globe.
Market Trends of the Global E-Prescription Market
The global e-prescription market is poised for significant growth, driven by the integration of e-prescribing software with Electronic Health Record (EHR) systems. This integration provides numerous advantages, including access to clinical notes, laboratory data, and clinical decision support tools, which standalone systems lack. By enhancing patient medication histories and pharmacy benefits information, EHR-connected e-prescriptions make critical drug data readily available, thereby reducing prescription errors in community healthcare settings. Additionally, increasing government initiatives to implement integrated EHR systems in hospitals further propel market expansion, highlighting the crucial role of technology in improving patient safety and healthcare efficiency.